Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 2/20 | 0.39 |
| ▸ | CTSL | P07711 | 7/20 | 0.39 |
| ▸ | CTSB | P07858 | 5/20 | 0.39 |
| ▸ | CTSK | P43235 | 5/20 | 0.39 |
| ▸ | TACR1 | P25103 | 1/20 | 0.38 |
| ▸ | CTSS | P25774 | 6/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25854641 | 0.90 | TACR1 (0.38) | PREPCTSLCTSBCTSKTACR1 | |
| SCHEMBL25855290 | 0.86 | TSHR (0.38) | — | |
| SCHEMBL25854678 | 0.85 | TSHR (0.37) | — | |
| SCHEMBL25855340 | 0.83 | ALDH1A1 (0.36) | CTSBCTSKCTSS | |
| SCHEMBL25862461 | 0.78 | HRH4 (0.34) | — | |
| SCHEMBL25854891 | 0.76 | MGLL (0.39) | CTSBCTSKCTSS | |
| SCHEMBL25854639 | 0.75 | MGLL (0.38) | CTSBCTSKCTSS | |
| SCHEMBL25854990 | 0.74 | TSHR (0.37) | — | |
| SCHEMBL27450139 | 0.70 | TACR1 (0.53) | PREPCTSLCTSBCTSKTACR1 | |
| SCHEMBL25526320 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227437-A1 | IMMUNOMODULATOR | HITGEN INC (CN) | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227437-A1 | IMMUNOMODULATOR | IL17A, IL2, IL2RA | PREP 1455/4885CTSL 1199/4885CTSB 728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.